Nypozi (filgrastim)

pCPA File Number: 21891
Negotiation Status:
Active Negotiation
Indication(s):
Prevention or treatment of neutropenia in various indications
Sponsor/Manufacturer:
Tanvex BioPharma USA, Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable